Ungual and periungual human papillomavirus–associated squamous cell carcinoma: A review - 10/08/11
Abstract |
Background |
Human papillomavirus (HPV)–associated squamous cell carcinoma (SCC) and SCC in situ are often reported in the genital region. The association of HPV with SCC in the ungual and periungual skin is less well recognized, and verrucous lesions may undergo years of therapeutic attempts without a diagnostic biopsy.
Objectives |
To review the epidemiology, associations, and role of HPV in digital SCC and SCC in situ.
Methods |
The English-language literature reporting HPV-associated SCC and SCC in situ of the digits was reviewed.
Results |
HPV-associated SCC and SCC in situ were almost equally represented. The patients' ages ranged from 22 to 89 years, with men affected twice as often as women. HPV16 was the most common subtype. The tumors presented as persistent verrucae, present for an average of 5.3 years. Immune suppression was documented in only 6.8% of patients. Approximately 6% of cases required digital amputation.
Limitations |
Most of the information was obtained from case reports, some of which had limited data regarding the exact location of the tumor and the diagnostic and treatment course. HPV subtyping is not commonly performed in these tumors, which limited the number of reports that could be evaluated.
Conclusions |
The majority of digital HPV-associated SCCs or SCCs in situ involves the nailbed region. The clinical appearance is most commonly that of a periungual verruca. Tumors have a higher rate of recurrence after excision than SCC in other sites. Periungual and subungual warts caused by high-risk HPV subtypes pose a risk for malignant transformation in both immunocompetent and immunocompromised hosts.
Le texte complet de cet article est disponible en PDF.Key words : human papillomavirus, periungual, squamous cell carcinoma, ungual, vaccine
Abbreviations used : HPV, SCC
Plan
Funding sources: None. |
|
Conflicts of interest: None declared. |
Vol 64 - N° 6
P. 1147-1153 - juin 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?